Described in a recent issue of the Proceedings of the National Academy of Sciences, the DNA nanotrain is a three-dimensional structure composed of short strands of DNA tethered together into one long train.
A three-year study conducted by University of Florida researchers, a first of its kind, will explore differences in morbidity, quality of life and survival among groups of culturally diverse black men with prostate cancer.
UF researchers have helped identify the underlying cause of a genetically derived, potentially fatal reaction to an anti-HIV medication, and have begun creating a less dangerous form of the drug.
Cancer treatment at Shands at the University of Florida is recognized among the nation’s best in the 2012-2013 U.S. News & World Report’s Best Hospitals rankings, which were released July [...]
Cancer Center researchers have developed a genetically-modified form of a meek microbe that deals a gutsy blow to colon cancer and has the potential to curb other immune disorders.
STOP! Children’s Cancer, Inc. donates $1 million to UF&Shands to support national clinical trials that provide the newest, cutting-edge cancer treatments to children with cancer.
We are the University of Florida Shands Cancer Center — more than 250 researchers and clinicians at UF and Shands HealthCare who provide cancer care and conduct research for the prevention, early diagnosis and treatment of cancer.
Our mission is and will always be dedicated to:
Providing state-of-the-art cancer treatment, prevention, control and education
Conducting original scientific research aimed at discovery
Fostering collaboration to turn research findings into new therapies
And, ultimately, offering hope in the face of a daunting diagnosis
Become a part of the UF Shands Cancer Center effort to generate tomorrow’s answers for today’s patients. Call (352) 273-8010 or email cancer-center@ufl.edu today.
Folakemi Odedina, Ph.D., a professor of pharmacy and the director of the UF Shands Cancer Center’s Cancer Health Disparities Program, served on the planning committee for National Cancer Institute Global [...]